Health-related quality of life in the ENDEAVOR study: carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed/refractory multiple myeloma

por Ludwig, Heinz, Moreau, Philippe, Dimopoulos, Meletios A., Mateos, Maria-Victoria, Kaiser, Martin, Hajek, Roman, Feng, Shibao, Cocks, Kim, Buchanan, Jaqueline, Weisel, Katja
Publicado 2019